AF
RYTM icon

Allworth Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Allworth Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
137
+54
+65% +$4.88K ﹤0.01% 3415
2026
Q1 		$7.22K Sell
83
-26
-24% -$2.53K ﹤0.01% 3730
2025
Q4 		$11.7K Sell
109
-22
-17% -$2.33K ﹤0.01% 3159
2025
Q3 		$13.2K Buy
131
+67
+105% +$6.22K ﹤0.01% 2962
2025
Q2 		$4.04K Buy
64
+14
+28% +$857 ﹤0.01% 3379
2025
Q1 		$3.15K Buy
+50
New +$2.77K ﹤0.01% 3019
2023
Q4 		– Sell
-5
Closed -$115 – 3598
2023
Q3 		$115 Buy
+5
New +$112 ﹤0.01% 3330

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allworth Financial's RYTM Position: Q2 2026 in Review

Allworth Financial increased its Rhythm Pharmaceuticals (RYTM) stake by 65% in Q2 2026, buying an estimated $4.88K and bringing the position to 137 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.

Allworth Financial first reported a position in RYTM in Q3 2023 and has held it in 7 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Allworth Financial held 137 shares of Rhythm Pharmaceuticals worth $15.2K as of Q2 2026.
  • Allworth Financial bought 54 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.88K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3415 holding.
  • Allworth Financial first reported a position in Rhythm Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.